Company / Operating Cash Flow per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.47
FY2025
5-year range
$0.73 / $1.47
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#47 of 212
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's operating cash flow per share of $1.47 is higher than 78% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $1.47.
Based on SEC 10-K filings.
1.47 in FY2025 with a 5-year CAGR of +4.4%. Top quartile in the Health Care sector.
Improved from $1.24 to $1.47 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- +4.4%
- 10-Year CAGR
- -
Sector benchmark
-72.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 31.2% year-over-year.
- Ranks #47 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.47 | +31.2% |
| FY2024 | $1.12 | -9.1% |
| FY2023 | $1.24 | -14.9% |
| FY2022 | $1.45 | +98.5% |
| FY2021 | $0.73 | -38.6% |
| FY2020 | $1.19 | +61.8% |
| FY2019 | $0.74 | -100.0% |
| FY2018 | $2545265.35 | +116224151.4% |
| FY2017 | $2.19 | -100.0% |
| FY2016 | $4047866.81 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026